IL6ST and hydrops fetalis: Although blood-based biomarkers have emerged as an accessible, cost-effective, and highly promising tool for improving early HF detection, measuring specific biomarkers such as IL6RB and ITIH3 remains uncommon in clinical practice in some settings.